Patrick Schöffski, MD, MPH
Head Department of General Medical Oncology
Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven Cancer Institute
Leuven, Vlaams-Brabant, Belgium
Luna De Sutter, MA (she/her/hers)
PhD student
Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven Cancer Institute
Leuven, Vlaams-Brabant, Belgium
Jasper Verreet, n/a
Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven Cancer Institute
Leuven, Vlaams-Brabant, Belgium
Ulla Vanleeuw
Lab technician
Laboratory of Experimental Oncology, Department of Oncology, KU Leuven and Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute
Leuven, Vlaams-Brabant, Belgium
Lore De Cock, MD
PhD student
Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven Cancer Institute
Leuven, Vlaams-Brabant, Belgium
Nina Linde, MD
The healthcare business of Merck KGaA
Darmstadt, Hessen, Germany
Christine Drechsler, MD
The healthcare business of Merck KGaA
Darmstadt, Hessen, Germany
Christina Esdar, PhD (she/her/hers)
Head Oncogenic Signaling Research
The healthcare business of Merck KGaA
Darmstadt, Hessen, Germany
Raf Sciot, MD, PhD
Department of Pathology, KU Leuven and University Hospitals Leuven
Leuven, Vlaams-Brabant, Belgium
Agnieszka Wozniak, PhD, DSc (she/her/hers)
Associate professor
Laboratory of Experimental Oncology, Department of Oncology, KU Leuven and Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute
Leuven, Vlaams-Brabant, Belgium